Page 13 - 南京医科大学学报自然科学版
P. 13
第42卷第1期 朱晓晗,刘晓蕊,李 琳,等. 利用CRISPR/Cas9技术高效构建巴马小型猪F9基因敲除细胞系[J].
2022年1月 南京医科大学学报(自然科学版),2022,42(01):001-007 · 7 ·
下来构建血友病乙巴马小型猪模型提供了重要的 [11] 曾华沙,姚 俊,王红顺,等. 人/猪OSBPL2同源性比较
原材料。 及猪 PFFs 靶基因敲除细胞系的建立[J]. 南京医科大
学学报(自然科学版),2018,38(2):149-154
[参考文献]
[12] ZHANG R,WANG Y,CHEN L,et al. Reducing immuno⁃
[1] LJUNG R. How I manage patients with inherited haemo⁃
reactivity of porcine bioprosthetic heart valves by geneti⁃
philia A and B and factor inhibitors[J]. Br J Haematol,
cally ⁃ deleting three major glycan antigens,GGTA1/β
2018,180(4):501-510
4GalNT2/CMAH[J]. Acta Biomater,2018,72:196-205
[2] STOOF S,KERSSEBOOM R,DE VRIES F,et al. Hemo⁃
[13] QU Y,NIE X,YANG Z,et al. The prevalence of hemo⁃
philia B in a female with intellectual disability caused by
philia in mainland China:a systematic review and meta⁃
a deletion of Xq26.3q28 encompassing the F9[J]. Mol
analysis[J]. Southeast Asian J Trop Med Public Health,
Genet Genomic Med,2018,6(6):1220-1224
2014,45(2):455-466
[3] DOLAN G,BENSON G,DUFFY A,et al. Haemophilia B:
[14] SHARMA A,EASOW M M,SRIGANESH V,et al. Gene
where are we now and what does the future hold?[J].
therapy for haemophilia[J]. Cochrane Database Syst Rev,
Blood Rev,2018,32(1):52-60
2016,12(12):CD010822
[4] GOODEVE A C. Hemophilia B:molecular pathogenesis
[15] WANG D,WANG K,CAI Y. An overview of development
and mutation analysis[J]. J Thromb Haemost,2015,13
in gene therapeutics in China[J]. Gene Ther,2020,27(7/
(7):1184-1195
8):338-348
[5] 王朝荣,余自强,孙 玲,等. 40 例血友病乙患者的基
[16] MONAHAN P E,SAMULSKI R J,TAZELAAR J,et al.
因分析及发病机制研究[J].中国实验血液学杂志,
Direct intramuscular injection with recombinant AAV
2013,21(4):963-968
vectors results in sustained expression in a dog model of
[6] GAO W,XU Y,LIU H,et al. Characterization of missense
hemophilia[J]. Gene Ther,1998,5(1):40-49
mutations in the signal peptide and propeptide of FIX in
hemophilia B by a cell⁃based assay[J]. Blood Adv,2020, [17] LIN H F,MAEDA N,SMITHIES O,et al. A coagulation
factor IX⁃deficient mouse model for human hemophilia B
4(15):3659-3667
[J]. Blood,1997,90(10):3962-3966
[7] HUANG L,LI L,LIN S,et al. Molecular analysis of 76
[18] CONG L,RAN F A,COX D,et al. Multiplex genome engi⁃
Chinese hemophilia B pedigrees and the identification of
neering using CRISPR/Cas systems[J]. Science,2013,
10 novel mutations[J]. Mol Genet Genomic Med,2020,8
339(6121):819-823
(11):e1482
[8] 李 杰,闫振宇.血友病鼠模型的构建及研究进展[J]. [19] CHEN F,WANG Y,YUAN Y,et al. Generation of B cell⁃
deficient pigs by highly efficient CRISPR/Cas9⁃mediated
中国比较医学杂志,2019,29(6):141-146
gene targeting[J]. J Genet Genomics,2015,42(8):437-
[9] NICHOLS T C,HOUGH C,AGERSØ H,et al. Canine
models of inherited bleeding disorders in the develop⁃ 444
ment of coagulation assays,novel protein replacement [20] YAO J,ZENG H,ZHANG M,et al. OSBPL2⁃disrupted
and gene therapies[J]. J Thromb Haemost,2016,14(5): pigs recapitulate dual features of human hearing loss and
894-905 hypercholesterolaemia[J]. J Genet Genomics,2019,46
[10] WATSON A L,CARLSON D F,LARGAESPADA D,et (8):379-387
al. Engineered swine models of cancer[J]. Front Genet, [收稿日期] 2020-10-26
2016,7:78 (本文编辑:蒋 莉)